News
= LISA News
18.12.2018
Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
18.12.2018
HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus
11.12.2018
Small but versatile – Key players in the marine nitrogen cycle can utilize cyanate and urea
04.12.2018
AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at ASH